tranexamic acid has been researched along with Cardiomyopathy, Dilated in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fritsch, N | 1 |
| Pouquet, O | 1 |
| Roux, B | 1 |
| Abdelmoumen, Y | 1 |
| Janvier, G | 1 |
1 other study available for tranexamic acid and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
[Successful use of recombinant factor VIIa in the control of a massive bleeding in two patients with biventricular assist device (Thoratec)].
Topics: Adult; Anticoagulants; Aprotinin; Blood Transfusion; Blood Transfusion, Autologous; Cardiac Tamponad | 2010 |